Megadose transplantation of highly purified haploidentical stem cells: Current results and future prospects

Pediatric Transplantation

Volumn 7, Issue SUPPL. 3, 2003, Pages 51-55

  Handgretinger, Rupert ^a   Klingebiel, Thomas ^b   Lang, Peter ^c   Gordon, Paul ^a   Niethammer, Dietrich ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; OKT 3; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CELL COUNT; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; T LYMPHOCYTE; TECHNIQUE; TREATMENT OUTCOME;

ANTIGENS, CD34; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES;

EID: 0347926540     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.7.s3.7.x     Document Type: Conference Paper

References (25)

1. Ho VT, SOIFFER RJ. The history and future of T cell depletion as graft-versus-host disease prophylaxis for allogencic hematopoietic stem cell transplantation. Blood 2001: 98: 3192-3204.
2. MILTENYI S, MULLER W, WEICHEL W, RADBRUCH A. High gradient magnetic cell separation with MACS. Cytometry 1990: 11: 231-238.
3. + cells using the CliniMACS device. J Hematother 1999: 8: 209-218.
4. + progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplant 1999: 24: 583-589.
5. KEEVER-TAYLOR CA, CRAIG A. et al. Complement-mediated T cell depletion of bone marrow: comparison of T10B9. 1A-31 and Muromonab-Orthoclone OKT3. Cytotherapy 2001: 3: 467-481.
6. CHAMPLIN RE, PASSWEG JR, ZHANG MJ, et al. T cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: Advantage of T cell antibodies with narrow specificities. Blood 2000: 95: 3996-4003.
7. HANDGRETINGER R, KLINGEBIEL T, LANG P, et al. Megadose transplantation of purified peripheral blood CD34 (+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001: 27: 777-783.
8. SCHLEGEL PG, EYRICH M, BADER P, et al. OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. Br J Haematol 2000: 111: 668-673.
9. GLUCKSBERG H, STORB R, FEFER A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974: 18: 295-304.
10. ZAUCHA JM, GOOLEY T, BENSINGER WI, et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001: 98: 3221-3227.
11. + selected blood cells from HLA-identical siblings. Blood 2002: 100: 724-727.
12. HANDGRETINGER R, LANG P, KLINGEBIEL T, NIETHAMMER D. CD34 stem cell dose and development of extensive chronic graft-versus-host disease. Blood 2002: 99: 3875-3876.
13. MEIJER E, SLAPER-CORTENBACH IC, THIJSEN SF, DEKKER AW, VERDONCK LF. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant 2002: 29: 335-339.
14. EYRICH M, LANG P, LAL S, et al. A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors. Br J Haematol 2001: 114: 422-432.
15. CHAMPLIN R, HESDORFFER C, LOWENBERG B, et al. Haplo-identical 'megadose' stem cell transplantation in acute leukemia: Recommendations for a protocol agreed upon at the Perugia and Chicago meetings. Leukemia 2002: 16: 427-428.
16. HALE G, COBBOLD S, NOVITZKY N, et al. CAMPATH-1 antibodies in stem-cell transplantation. Cytotherapy 2001: 3: 145-164.
17. FRY TJ, MACKALL CL. Interleukin-7: Master regulator of peripheral T cell homeostasis? Trends Immunol 2001: 22: 564-571.
18. FRY TJ, MACKALL CL. Interleukin-7: From bench to clinic. Blood 2002: 99: 3892-3904.
19. EINSELE H, ROOSNEK E, RUFER N, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002: 99: 3916-3922.
20. KOH MB, PRENTICE HG, CORBO M, et al. Alloantigen-specific T cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. Br J Haematol 2002: 118: 108-116.
21. RUGGERI L, CAPANNI M, URBANI E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002: 295: 2097-2100.
22. FARAG SS, FEHNIGER TA, RUGGERI L, VELARDI A, CALIGIURI MA. Natural killer cell receptors, new biology and insights into the graft-versus-leukemia effect. Blood 2002: 100: 1935-947.
23. VELARDI A, RUGGERI L, MORETTA A, MORETTA L. NK cells: A lesson from mismatched hematopoietic transplantation. Trends Immunol 2002: 23: 438.
24. RUGGERI L, CAPANNI M, CASUCCI M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999: 94: 333-339.
25. GORDON PR, LEIMIG T, MUELLER I, et al. A large-scale method for T cell depletion, towards graft engineering of mobilized peripheral blood stem cells. Bone Marrow Transplant 2002: 30: 69-74.